Alnylam Pharmaceuticals (ALNY) PT Lowered to $111 at Stifel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Alnylam Pharmaceuticals (ALNY) PT Lowered to $111 at Stifel

Alnylam Pharmaceuticals (ALNY) PT Lowered to $116 at BMO Capital

November 8, 2018 8:56 AM EST

BMO Capital analyst Do Kim lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $116.00 (from $124.00) while maintaining a Outperform rating.

Kim commented, "We lower our estimates and target price to $116 from $124, following 3Q18 earnings that saw modest initial Onpattro sales... More